Module

Update on the Management of HBV

Source: Hepatitis Annual Update 2006

Update on the Management of HBV

Program Director: Emmet B. Keeffe, MD, MACP

Faculty:
Marc G. Ghany, MD

CME CREDIT INFORMATION

Release Date: 07/27/06

Expiration Date: 07/26/07

Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Pharmacists: 1.1 contact hours (0.11 CEUs)

Registered Nurses: 1.3 Nursing CE credits

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe the purpose of the National Institutes of Health (NIH) workshop on management of Hepatitis B
Review the conclusions of the NIH workshop
Discuss the unresolved issues and challenges raised by the workshop

Topics covered include:

Introduction
Initial Assessment of HBV Infection
Controversy: Which Assay Is Most Appropriate for HBV DNA Quantification?
Controversy: Should Initial Patient Assessment Include HBV Genotyping?
Whom to Treat?
Monitoring Hepatitis B Patients
What Is the Role of Liver Biopsy in the Management of Chronic Hepatitis B?
Definitions
Recommendations for Therapy
Resistance Testing
Conclusion and Summary

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.